 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Biohaven Announces Pricing of $230 Million Public Offering of Common Shares Biohaven Announces Pricing of $230 Million Public Offering of Common Shares PR Newswire NEW HAVEN, Conn., April 18, 2024...

Biohaven Announces Pricing of $230 Million Public Offering of Common Shares

Biohaven Announces Proposed Public Offering of Common Shares Biohaven Announces Proposed Public Offering of Common Shares PR Newswire NEW HAVEN, Conn., April 17, 2024 NEW HAVEN, Conn., April 17, 2024...

Biohaven Announces Proposed Public Offering of Common Shares

Biohaven Showcases Innovative Neuroscience Portfolio with 20 Presentations at the 2024 American Academy of Neurology (AAN) Annual Meeting and Provides Other Business Updates Biohaven Showcases...

Biohaven Showcases Innovative Neuroscience Portfolio with 20 Presentations at the 2024 American Academy of Neurology (AAN) Annual Meeting and Provides Other Business Updates

Biohaven Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Business Developments Biohaven Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Business...

Biohaven Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Business Developments

Biohaven Highlights Progress Across Innovative Portfolio and Outlines 2024 Anticipated Milestones at the 42nd Annual J.P. Morgan Healthcare Conference; Established Extensive Portfolio Across 20...

Biohaven Highlights Progress Across Innovative Portfolio and Outlines 2024 Anticipated Milestones at the 42nd Annual J.P. Morgan Healthcare Conference; Established Extensive Portfolio Across 20 Therapeutic Indications in Neuroscience, Immunology and Oncol

Biohaven to Present at the 42nd Annual J.P. Morgan Healthcare Conference Biohaven to Present at the 42nd Annual J.P. Morgan Healthcare Conference PR Newswire NEW HAVEN, Conn., Jan. 2, 2024 NEW HAVEN...

Biohaven to Present at the 42nd Annual J.P. Morgan Healthcare Conference

Biohaven Ltd. is a global clinical stage biopharmaceutical company, which engages in the discovery, development, and commercialization of therapies for people with neurological and neuropsychiatric diseases. The company was founded on May 2, 2022 and is headquartered in New Haven, CT.

Volume (M)	445,240.00
52-Wk High	$62.21
52-Wk Low	$12.35

BHVN Biohaven Pharmaceutical Holding Company Ltd

About

Feed

News

Sentiment

Earnings

Fundamentals